Pronóstico del mercado europeo de pruebas desarrolladas en laboratorio hasta 2028: impacto de COVID-19 y análisis regional por tipo (bioquímica clínica, cuidados intensivos, hematología, microbiología, diagnóstico molecular, inmunología y otros tipos de pruebas) y aplicación (institutos académicos, organizaciones de investigación clínica, hospitales) Laboratorio, Centros de Diagnóstico de Especialidades y Otros)

Introducción al mercado

Una prueba desarrollada en laboratorio (LDT) es un tipo de prueba de diagnóstico in vitro que está diseñada y utilizada dentro un solo laboratorio. Estas pruebas se pueden utilizar para estimar o distinguir una amplia variedad de materiales analitos, como proteínas, compuestos químicos como glucosa o colesterol, o ADN, a partir de una muestra obtenida de la anatomía humana. Se prevé que la expansión de los métodos automatizados de diagnóstico in vitro (IVD) para que los laboratorios y dispensarios realicen análisis precisos y sin errores impulse el incremento.

Visión general y dinámica del mercado

Se prevé que el mercado europeo de pruebas desarrolladas en laboratorio alcance los 8.988,78 millones de dólares EE.UU. al 2028 desde US$ 5.664,43 millones en 2021; se estima que crecerá a una tasa compuesta anual del 6,8 % entre 2021 y 2028. La creciente incidencia de cáncer y trastornos genéticos y el creciente número de lanzamientos de productos en toda Europa son factores que impulsan el mercado de pruebas desarrolladas en laboratorio. Sin embargo, el cambiante panorama regulatorio está obstaculizando el crecimiento del mercado de pruebas de desarrollo de laboratorio.

Los LDT se desarrollan y utilizan dentro de los laboratorios y no se distribuyen ni se venden a otros laboratorios o instalaciones sanitarias. Estas pruebas están diseñadas para superar el desafío de la falta de disponibilidad de pruebas comerciales. Muchas LDT son pruebas genéticas desarrolladas para enfermedades raras. Por lo tanto, la frecuencia de desarrollo e introducción de nuevos LDT es alta. En noviembre de 2020, Aditx Therapeutics, Inc recibió una certificación CLIA para las operaciones del laboratorio AditxtScore para monitoreo inmunológico, lo que les permitió lanzar la prueba AditxtScore para diagnosticar COVID-19. La creciente aparición de variantes del SARS-CoV-2 ha puesto de relieve la necesidad de identificar, rastrear y rastrear mutaciones en todo el genoma viral. En enero de 2021, Eurofins lanzó la prueba NovaType para detectar y monitorear nuevas variantes del SARS-CoV-2. Este ensayo de RT-PCR está clínicamente validado para identificar las variantes B.1.1.7 y B.1.351 en poco tiempo. NovaType ya está disponible como LDT en Alemania y estará disponible en más de 50 laboratorios Eurofins en todo el mundo para realizar pruebas de detección de COVID-19 en pacientes. Además, la creciente demanda de medicina personalizada está ofreciendo importantes oportunidades de crecimiento para los actores que operan en el mercado europeo de pruebas desarrolladas en laboratorio.

Los países de toda Europa están presenciando un resurgimiento de la COVID-19 casos después de mitigar exitosamente la pandemia. Muchos países están declarando más casos cada día que en la primera ola de 2020. Los gobiernos de muchos países están trabajando para ampliar la capacidad de pruebas, lo que está impulsando aún más el mercado de pruebas desarrolladas en laboratorio. Muchos actores del mercado han lanzado productos para satisfacer la creciente demanda. Por ejemplo, en agosto de 2020, Eurofins Technologies (Luxemburgo) lanzó una gama de kits de prueba para la detección de anticuerpos basada en serología mediante ELISA de pacientes expuestos a la COVID-19. Estas pruebas están diseñadas para cumplir con los requisitos específicos de la región para COVID-19. Viracor Eurofins recibió la Autorización de uso de emergencia (EUA) de la Administración de Alimentos y Medicamentos (FDA) para su prueba desarrollada en laboratorio de SARS-CoV-2. Otros laboratorios de Eurofins han desarrollado opciones alternativas de RT-PCR para cumplir con las obligaciones regulatorias locales y mitigar los problemas de la cadena de suministro de reactivos a nivel mundial. Sin embargo, otras pruebas que no son de emergencia experimentaron una caída debido a las medidas de bloqueo y a las instituciones de salud sobrecargadas.

Segmentos de mercado clave

El mercado europeo de pruebas desarrolladas en laboratorio, por tipo, está segmentado en bioquímica clínica, cuidados críticos, hematología, microbiología, diagnóstico molecular e inmunología. y otros tipos de pruebas. El segmento de hematología se subsegmentó en coagulación y hemostasia, pruebas de hemoglobina, pruebas de hemograma y otros. Se espera que el segmento de diagnóstico molecular tenga la mayor participación de mercado en 2021. Sin embargo, se anticipa que el segmento de hematología registre la CAGR más alta durante el período de pronóstico.

El laboratorio europeo desarrolló El mercado de pruebas, por aplicación, se segmenta en institutos académicos, organizaciones de investigación clínica, laboratorios de hospitales, centros de diagnóstico especializados y otros. Se espera que el segmento de laboratorios de hospitales tenga la mayor participación de mercado en 2021. Sin embargo, se anticipa que el segmento de centros de diagnóstico especializados registre la CAGR más alta durante el período de pronóstico.

Principales fuentes y empresas enumeradas

Algunas de Las fuentes primarias y secundarias a las que se hace referencia al preparar el informe del mercado europeo de pruebas desarrolladas en laboratorio son la Asociación Alemana de la Industria del Diagnóstico (VDGH), Deutsche Akkreditierungsstelle GmbH (DAkkS) y la Fundación Española del Corazón (FEC).

Razones para comprar el informe

Determinar posibles áreas de inversión basándose en un análisis detallado de tendencias del mercado europeo de pruebas desarrolladas en laboratorio durante los próximos años.
Obtener una comprensión profunda de los factores subyacentes que impulsan la demanda de diferentes segmentos terapéuticos contra las adicciones en los países con mayor gasto y identifica las oportunidades que ofrece cada uno de ellos.
Fortalece tu conocimiento del mercado en términos de impulsores de la demanda, tendencias de la industria y los últimos desarrollos tecnológicos, entre otros.
Identificar los principales canales que impulsan el mercado europeo de diltiazem, proporcionando una imagen clara de las oportunidades futuras que ayudará a analizar, lo que resultará en una expansión de los ingresos.
Canalizar recursos enfocándose en los programas en curso emprendidos por los diferentes países dentro del Mercado de pruebas desarrollado por laboratorios en Europa.

SEGMENTACIÓN DEL MERCADO DE PRUEBAS DESARROLLADAS POR LABORATORIOS EUROPEOS

Por tipo

Bioquímica Clínica
Cuidados Críticos
Hematología

- Coagulación y hemostasia,
- Prueba de hemoglobina
- Prueba de recuento sanguíneo
- Otros

Inmunología
Microbiología
Diagnóstico molecular
Otros tipos de pruebas

Por Aplicación

Institutos académicos
Organizaciones de investigación clínica
Laboratorios de hospitales
Especialidad Centros de diagnóstico
Otros

Por país

Perfiles de la empresa

TABLE OF CONTENTS

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Europe Laboratory Developed Test Market – By Type

1.3.2 Europe Laboratory Developed Test Market – By Application

1.3.3 Europe Laboratory Developed Test Market – By Country

2. Laboratory Developed Test Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Laboratory Developed Test Market – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 Europe– PEST Analysis

4.3 Experts Opinion

5. Laboratory Developed Test Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Increasing Incidence of Cancer and Genetic Disorders

5.1.2 Large Number of Product Launches

5.2 Market Restraints

5.2.1 Changing Regulatory Landscape

5.3 Market Opportunities

5.3.1 Continuous Research on Personalized Medicine

5.4 Future Trends

5.4.1 Automation of Laboratory Processes

5.5 Impact Analysis

6. Laboratory Developed Test Market –Europe Analysis

6.1 Europe Laboratory Developed Test Market Revenue Forecast and Analysis

7. Laboratory Developed Test Market Analysis – By Type

7.1 Overview

7.2 Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

7.3 Clinical Biochemistry

7.3.1 Overview

7.3.2 Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4 Haematology

7.4.1 Overview

7.4.2 Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3 Coagulation and Hemostasis

7.4.3.1 Overview

7.4.3.2 Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4 Hemoglobin Testing

7.4.4.1 Overview

7.4.4.2 Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.5 Blood Count Testing

7.4.5.1 Overview

7.4.5.2 Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.4.6 Others

7.4.6.1 Overview

7.4.6.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.5 Immunology

7.5.1 Overview

7.5.2 Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.6 Critical Care

7.6.1 Overview

7.6.2 Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.7 Microbiology

7.7.1 Overview

7.7.2 Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.8 Molecular Diagnostics

7.8.1 Overview

7.8.2 Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

7.9 Other Test Types

7.9.1 Overview

7.9.2 Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8. Laboratory Developed Test Market Analysis – By Application

8.1 Overview

8.2 Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

8.3 Academic Institutes

8.3.1 Overview

8.3.2 Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.4 Clinical Research organizations

8.4.1 Overview

8.4.2 Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.5 Hospital laboratory

8.5.1 Overview

8.5.2 Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.6 Specialty Diagnostic Centers

8.6.1 Overview

8.6.2 Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

8.7 Others

8.7.1 Overview

8.7.2 Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

9. Laboratory Developed Test Market – Europe Analysis

9.1 Europe: Laboratory Developed Test Market

9.1.1 Overview

9.1.3 Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

9.1.3.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.1 Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.1.2 Germany: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.1.2.1 Germany: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.1.3 Germany: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.2 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.1 France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.2.2 France: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.2.2.1 France: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.2.3 France: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.3 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.1 UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.3.2 UK: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.3.2.1 UK: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.3.3 UK: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.4 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.1 Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.4.2 Italy: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.4.2.1 Italy: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.4.3 Italy: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.5 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.1 Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.5.2 Spain: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.5.2.1 Spain: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.5.3 Spain: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

9.1.3.6 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.1 Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

9.1.3.6.2 Rest of Europe: Laboratory Developed Test Market, By Type, 2019–2028 (USD Million)

9.1.3.6.2.1 Rest of Europe: Laboratory Developed Test Market, by Haematology, 2019–2028 (USD Million)

9.1.3.6.3 Rest of Europe: Laboratory Developed Test Market, by Application, 2019–2028 (USD Million)

10. Impact Of COVID-19 Pandemic on Laboratory Developed Test Market

10.1 Europe: Impact Assessment of COVID-19 Pandemic

11. Laboratory Developed Test Market–Industry Landscape

11.1 Overview

11.2 Inorganic Growth Strategies

11.2.1 Overview

11.3 Organic Growth Strategies

11.3.1 Overview

12. Company Profiles

12.1 Quest Diagnostics Incorporated

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 F.HOFFMANN-LA ROCHE LTD.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 QIAGEN

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 Illumina, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Eurofins Scientific

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.7 Guardant Health

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. Germany: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 2. Germany Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 3. Germany: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 4. France: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 5. France Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 6. France: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 7. UK: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 8. UK Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 9. UK: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 10. Italy: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 11. Italy Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 12. Italy: Laboratory Developed Test Market, by Application– Revenue and Forecast to 2028 (USD Million)

Table 13. Spain: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 14. Spain Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 15. Spain: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 16. Rest of Europe: Laboratory Developed Test Market, By Type – Revenue and Forecast to 2028 (USD Million)

Table 17. Rest of Europe Laboratory Developed Test Market, by Haematology – Revenue and Forecast to 2028 (USD Million)

Table 18. Rest of Europe: Laboratory Developed Test Market, by Application – Revenue and Forecast to 2028 (USD Million)

Table 19. Recent Inorganic Growth Strategies in the Laboratory Developed Test Market

Table 20. Recent Organic Growth Strategies in the Laboratory Developed Test Market

Table 21. Glossary of Terms, Laboratory Developed Test Market

LIST OF FIGURES

Figure 1. Laboratory Developed Test Market Segmentation

Figure 2. Laboratory Developed Test Market Segmentation, By Country

Figure 3. Europe Laboratory Developed Test Market Overview

Figure 4. Molecular Diagnostics Segment Held the Largest Share of the Type Segment in Laboratory Developed Test Market

Figure 5. Europe Laboratory Developed Test Market – Leading Country Markets (US$ Million)

Figure 6. Europe and PEST Analysis

Figure 1. Laboratory Developed Test Market Impact Analysis of Drivers and Restraints

Figure 2. Europe Laboratory Developed Test Market – Revenue Forecast and Analysis – 2020- 2028

Figure 3. Laboratory Developed Test Market Revenue Share, by Type (2021 and 2028)

Figure 4. Clinical Biochemistry: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 5. Haematology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 6. Coagulation and Hemostasis: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 7. Hemoglobin Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 8. Blood Count Testing: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 9. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 10. Immunology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 11. Critical Care: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12. Microbiology: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13. Molecular Diagnostics: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14. Other Test Types: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15. Laboratory Developed Test Market Revenue Share, by Application (2021 and 2028)

Figure 16. Academic Institutes: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17. Clinical Research organizations: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18. Hospital laboratory: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19. Specialty Diagnostic Centers: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20. Others: Laboratory Developed Test Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21. Europe: Laboratory Developed Test Market, by Key Country – Revenue (2021) (USD Million)

Figure 22. Europe: Laboratory Developed Test Market, by Country, 2021 & 2028 (%)

Figure 23. Germany: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 24. France: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 25. UK: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 26. Italy: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 27. Spain: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 28. Rest of Europe: Laboratory Developed Test Market – Revenue and Forecast to 2028 (USD Million)

Figure 29. Impact of COVID-19 Pandemic in European Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe laboratory developed test market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe laboratory developed test market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Europe Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software and Serv..	May 2022
Europe Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Electric P..	May 2022
Europe In-Office Teeth Whitening Products Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product (Double-Syringe Mixing Configurat..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000

$3000

GET FREE SAMPLE PDF

Inquire before Buying Inquire for Discount

Subscription Member Price: FREE

Get Subscription

Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis.

Request for Free Sample